PRS6 A Model for Determining the Budget Impact of Introducing a New Single-Inhaler Triple Combination Therapy for Managing Moderate to Very Severe COPD in the United States
Abstract
Authors
D. Erim M. Pollack N. Feigler
D. Erim M. Pollack N. Feigler
ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now